US 9080174
HBV treatment
granted A61PA61P31/20
Quick answer
US patent 9080174 (HBV treatment) held by Benitec Biopharma Limited expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Benitec Biopharma Limited
- Grant date
- Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P31/20